Centre Hospitalier Universitaire De Bordeaux

At Centre Hospitalier Universitaire De Bordeaux, clinical trials in genetic phenomena focus on inherited and complex conditions such as Megalencephaly-CApillary malformation Polymicrogyria syndrome and myelin oligodendrocyte glycoprotein antibody associated disease. This work is aimed at better understanding disease behavior and evaluating new treatment options that may improve long-term outcomes for patients with rare disorders.

• Research on MCAP syndrome is exploring whether a targeted therapy can improve adaptive behavior and broader disease symptoms.
• Studies in MOG-AD are assessing relapse prevention and the effectiveness of immunosuppressive treatment after an initial attack.

These trials reflect a strong interest in precision medicine for uncommon neurological and developmental conditions.

The site is also active in trials for rheumatoid arthritis and systemic sclerosis, two conditions that affect the immune system and connective tissues. The research is centered on comparing treatment strategies, improving symptom control, and finding better ways to preserve function and quality of life.

• In rheumatoid arthritis, investigators are evaluating whether a sequential treatment approach can improve remission rates compared with routine care.
• In systemic sclerosis, trials are examining whether a new therapy can support lung function and reduce disease impact.

This area highlights ongoing efforts to refine autoimmune disease management through more effective treatment selection.

Clinical research at this Bordeaux hospital includes studies in COVID-19, with attention to both moderate and severe illness in hospitalized patients. The main goal is to evaluate whether different therapeutic approaches can reduce disease progression and improve survival in serious viral infection.

• Trials in coronavirus disease are testing treatment strategies for hospitalized patients with moderate COVID-19.
• Additional work focuses on patients with severe or critical COVID-19, including those who are immunocompromised.

This research supports better care decisions in emerging infectious diseases and severe respiratory illness.

The site conducts obstetric research on premature rupture of membranes in pregnant women, with a focus on improving the chances of timely vaginal birth and understanding patient experience. These studies are designed to compare approaches used to support labor induction when the cervix is unfavorable.

• Trials are comparing methods such as balloon catheter with oxytocin versus oral misoprostol.
• Research also includes assessment of patient satisfaction with the care pathway.

This work aims to improve practical management in obstetrics while keeping patient-centered outcomes in view.